rs28910270

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001184.4(ATR):​c.1950G>A​(p.Glu650Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0196 in 1,614,042 control chromosomes in the GnomAD database, including 399 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 29 hom., cov: 32)
Exomes 𝑓: 0.020 ( 370 hom. )

Consequence

ATR
NM_001184.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.32

Publications

14 publications found
Variant links:
Genes affected
ATR (HGNC:882): (ATR serine/threonine kinase) The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]
ATR Gene-Disease associations (from GenCC):
  • Seckel syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
    Inheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial prostate carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 3-142556511-C-T is Benign according to our data. Variant chr3-142556511-C-T is described in ClinVar as Benign. ClinVar VariationId is 157968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.32 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0178 (2705/152282) while in subpopulation SAS AF = 0.0411 (198/4822). AF 95% confidence interval is 0.0364. There are 29 homozygotes in GnomAd4. There are 1271 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 29 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRNM_001184.4 linkc.1950G>A p.Glu650Glu synonymous_variant Exon 9 of 47 ENST00000350721.9 NP_001175.2 Q13535-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRENST00000350721.9 linkc.1950G>A p.Glu650Glu synonymous_variant Exon 9 of 47 1 NM_001184.4 ENSP00000343741.4 Q13535-1

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2705
AN:
152164
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0124
Gnomad ASJ
AF:
0.0326
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0414
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0184
Gnomad OTH
AF:
0.0186
GnomAD2 exomes
AF:
0.0181
AC:
4557
AN:
251250
AF XY:
0.0196
show subpopulations
Gnomad AFR exome
AF:
0.0188
Gnomad AMR exome
AF:
0.0110
Gnomad ASJ exome
AF:
0.0296
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00360
Gnomad NFE exome
AF:
0.0183
Gnomad OTH exome
AF:
0.0193
GnomAD4 exome
AF:
0.0198
AC:
28979
AN:
1461760
Hom.:
370
Cov.:
31
AF XY:
0.0204
AC XY:
14839
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.0200
AC:
669
AN:
33478
American (AMR)
AF:
0.0113
AC:
507
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0307
AC:
802
AN:
26128
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39686
South Asian (SAS)
AF:
0.0412
AC:
3554
AN:
86248
European-Finnish (FIN)
AF:
0.00376
AC:
201
AN:
53410
Middle Eastern (MID)
AF:
0.0380
AC:
219
AN:
5768
European-Non Finnish (NFE)
AF:
0.0195
AC:
21652
AN:
1111942
Other (OTH)
AF:
0.0227
AC:
1369
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1544
3088
4633
6177
7721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0178
AC:
2705
AN:
152282
Hom.:
29
Cov.:
32
AF XY:
0.0171
AC XY:
1271
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0210
AC:
874
AN:
41554
American (AMR)
AF:
0.0124
AC:
190
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0326
AC:
113
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.0411
AC:
198
AN:
4822
European-Finnish (FIN)
AF:
0.00283
AC:
30
AN:
10602
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0184
AC:
1255
AN:
68034
Other (OTH)
AF:
0.0184
AC:
39
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
139
279
418
558
697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0194
Hom.:
11
Bravo
AF:
0.0179
Asia WGS
AF:
0.0270
AC:
93
AN:
3478
EpiCase
AF:
0.0224
EpiControl
AF:
0.0200

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Nov 02, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The ATR c.1950G>A variant affects a non-conserved nucleotide, resulting in no amino acid change. Mutation Taster predicts the variant is a polymorphism, and 3/5 Alamut algorithms predict no significant change in splicing. Additionally, the variant has been reported as a polymorphism in the literature (PMID: 26695994). This variant was found in 2283/120952 control chromosomes (48 homozygotes) at a frequency of 0.0188753, which is about 30200 times the maximal expected frequency of a pathogenic ATR allele (0.0000006), suggesting this variant is benign. Furthermore, one clinical laboratory classified this variant as benign. Taken together, this variant was classified as benign. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Seckel syndrome 1 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 02, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.9
DANN
Benign
0.42
PhyloP100
-1.3
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28910270; hg19: chr3-142275353; COSMIC: COSV63385666; API